/nobg_ncis-ncam-2026-logo-master0255ec98-462e-427a-9656-287732e60b04.jpeg?sfvrsn=e8531c79_1){kind=logo}
Rational De-Escalation in Cancer Treatment: From More to Meaningful
Friday, 28 August 2026
| Morning Session | Programme |
|---|---|
| 9.00 am | Opening Address Prof Chng Wee Joo Senior Consultant, Division of Haematology, Department of Haematology-Oncology, National University Cancer Institute, Singapore Professor, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore Yong Loo Lin Professor in Medical Oncology, Yong Loo Lin School of Medicine, National University of Singapore Vice President (Biomedical Sciences Research), Office of the Deputy President (Research and Technology), National University of Singapore Group Chief Scientist, National University Health System |
Education Session Session Chairperson: A/Prof David Tan Shao Peng | |
| 9.10 am | Rational De-escalation in Cancer Treatment in Acute Lymphoblastic Leukaemia (ALL): Lessons from the Malaysia-Singapore (Ma-Spore) ALL studies. Prof Allen Yeoh Head of Division & Senior Consultant, Division of Paediatric Haematology and Oncology.
|
| 9.30 am | Rational Deescalation in Cancer Treatment: Radiation Oncologist's Perspective Dr Soon Yu Yang Senior Consultant, Department of Radiation Oncology, National University Cancer Institute, Singapore |
| 9.50 am | When More is Not Better in Cancer Treatment Dr Yong Wei Peng Senior Consultant, Department of Haematology-Oncology, National University Cancer Institute, Singapore |
| 10.10 am | Tea Break |
Oral Abstract Presentation - Basic Sciences | |
| 10.55 am | Inverse RNA editing in hepatocytes and T cells regulates cytotoxicity in Hepatocellular Carcinoma Dr Wei Liang Gan Cancer Science Institute of Singapore, National University of Singapore |
| 11.10 am | EZH2 modulates mTOR drug sensitivity in DLBCL Mr Reinhard Brunmeir Cancer Science Institute of Singapore, National University of Singapore |
| 11.25 am | Examining the Impact of Intercellular Oncoprotein Transfer on the Development of Drug-Resistant Clones in Lung Cancer Dr Jie Qing Eu Cancer Discovery and Regenerative Medicine Programme, Lee Kong Chian School of Medicine, Nanyang Technology University |
Oral Abstract Presentation - Translational Sciences | |
| 11.40 am | CD47 blockade-driven necroptosis complements BCL-2 inhibition-driven apoptosis in hematologic malignancies Dr Stephen Jun Fei Chong Cancer Science Institute of Singapore, National University of Singapore |
| 11.55 am | Polygenic and classical risk integration reshapes breast cancer screening recommendations in 9,761 Asian women Dr Jingmei Li Genome Institute of Singapore, A*STAR |
| 12.10 pm | Prospective functional precision oncology in metastatic breast cancer supports clinical utility and therapeutic vulnerability discovery Dr Dexter Kai Hao Thng The N.1 Institute for Health, National University of Singapore |
| 12.25 pm | Lunch |
| Afternoon Session | Programme |
|---|---|
Oral Abstract Presentation - Clinical Sciences | |
| 2.00 pm | A phase II study of afatinib in patients with advanced non-small cell lung cancer (NSCLC) harbouring P-loop αC helix compressing EGFR mutations Dr Kenneth Sooi Department of Haematology-Oncology, National University Cancer Institute, Singapore |
| 2.15 pm | Phase IIa Dose-Expansion Study of OPB-111077 in An Enriched Population of Treatment-Refractory Advanced Solid Tumors Dr Laura Shih Hui Goh Ng Teng Foong General Hospital Internal Medicine, National University Health System |
| 2.30 pm | Temporal Gut Microbiome Signatures Associated with Response and Toxicity to Immune Checkpoint Inhibitors in Asian NSCLC Dr Yiqing Huang Department of Haematology-Oncology, National University Cancer Institute, Singapore |
Oral Abstract Presentation - Nursing / Paramedical / Supportive Care | |
| 2.45 pm | Driving Appropriate Care at the End-Of-Life (AptEOL) in Cancer Patients Dr Choo Kexin Amanda National University Cancer Institute, Singapore, National University Health System |
| 3.00 pm | Clinician Prediction of Survival Can Identify Patients for Appropriate Care at the End-of-Life (AptEOL) Dr Wang Yanjun Division of Oncology Nursing, National University Cancer Institute, Singapore |
| 3.15 pm | NCIS@Home: Pilot Implementation of an Oncology Hospital at Home Programme Dr Yi Qing Tey Department of Haematology-Oncology, National University Cancer Institute, Singapore, |
| 3.30 pm | Refreshments |
Plenary Session Session Chairperson: Prof Goh Boon Cher | |
| 3.45 pm | Radical Thinking for a Precision Future in Cancer Medicine Prof Edison Liu President Emeritus and Professor, The Jackson Laboratory |
Hear the Journey Session Session Chairperson: Dr Anand Devaprasath Jeyasekharan | |
| 4.20 pm | The People, the Journey, and the Why in Academic Medicine Dr Cinnie Yentia Soekojo Consultant, Division of Haematology, Department of Haematology-Oncology, National University Cancer Institute, Singapore Assistant Professor, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore |
| 4.40 pm | From Medical Roots to RNA and Cancer Research A/Prof Polly Chen Principal Investigator & Research Director, Cancer Science Institute of Singapore, National University of Singapore Associate Professor & Assistant Head, Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore |
| 5.00 pm | Cocktail and Networking Session |
| 5.30 pm | Announcement of Award Winners |
| 5.45 pm | Closing Address Adj A/Prof Chee Cheng Ean Senior Consultant, Department of Haematology-Oncology, National University Cancer Institute, Singapore Adjunct Associate Professor, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore Executive Director, National University Cancer Institute, Singapore |
Contact our conference secretariat at Enquiries NCAM (NUH) enquiries_ncam@nuhs.edu.sg
